Oncogenic miR-9 is a target of erlotinib in NSCLCs
2015 · Scientific Reports · 60 citations
https://doi.org/10.1038/srep17031
X
Xuerong Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
173
Papers
4.5K
Citations
35
h-index
72
i10-index
Xuerong Wang is an academic researcher from The University of Sydney. The author has contributed to research in topics: PI3K/AKT/mTOR signaling in cancer & Cancer-related gene regulation & Kruppel-like factors research. The author has an h-index of 35, co-authored 148 publications.
ORCID: 0000-0002-3040-9435Papers by this author
worksMultiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36
2012 · Journal of Lipid Research · 31 citations
https://doi.org/10.1194/jlr.m029991
Targeting inflammation with chimeric antigen receptor macrophages using a signal switch
2025 · Nature Biomedical Engineering · 19 citations
https://doi.org/10.1038/s41551-025-01387-8
Trichostatin A downregulates bromodomain and extra-terminal proteins to suppress osimertinib resistant non-small cell lung carcinoma
2021 · Cancer Cell International · 15 citations
https://doi.org/10.1186/s12935-021-01914-y
Factors affecting the outcome of full pulpotomy in permanent posterior teeth diagnosed with reversible or irreversible pulpitis
2022 · Scientific Reports · 15 citations
https://doi.org/10.1038/s41598-022-24815-0
Clinical application of bronchoalveolar lavage fluid metagenomics next-generation sequencing in cancer patients with severe pneumonia
2024 · Respiratory Research · 14 citations
https://doi.org/10.1186/s12931-023-02654-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat